Innovation Pharmaceuticals Inc (IPIX)

[buffwilliam]

To those of you who have clinical trial knowledge, even though the top line showed no difference in the mortality rate, do not the secondary end points such as viral loads at beginning and at end have any value? I can't recall what other secondary end points there are, but there may be other valuable information gleaned from the trial that could be of importance to treat early onset of this and other viruses.